Q1 2022 13F Holders as of 31 Mar 2022
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
61,990,594
-
Share change
-
+3,793,047
-
Total reported value
-
$300,611,133
-
Put/Call ratio
-
126%
-
Price per share
-
$4.85
-
Number of holders
-
159
-
Value change
-
-$32,203,990
-
Number of buys
-
83
-
Number of sells
-
67
Institutional Holders of BLUEBIRD BIO INC - COM (BLUE) as of Q1 2022
As of 31 Mar 2022,
BLUEBIRD BIO INC - COM (BLUE) was held by
159 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
61,990,594 shares.
The largest 10 holders included
STATE STREET CORP, WELLINGTON MANAGEMENT GROUP LLP, VANGUARD GROUP INC, BlackRock Inc., BAKER BROS. ADVISORS LP, CREDIT SUISSE AG/, GOLDMAN SACHS GROUP INC, JPMORGAN CHASE & CO, MORGAN STANLEY, and TANG CAPITAL MANAGEMENT LLC.
This page lists
159
institutional shareholders reporting positions in this security
for the Q1 2022 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.